Prelude Therapeutics
PRLD
PRLD
58 hedge funds and large institutions have $26.9M invested in Prelude Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 24 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
58
Holding in Top 10
–
Calls
$18K
Puts
–
Top Buyers
| 1 | +$373K | |
| 2 | +$159K | |
| 3 | +$41K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$31.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$26.8K |
Top Sellers
| 1 | -$850K | |
| 2 | -$630K | |
| 3 | -$498K | |
| 4 |
Millennium Management
New York
|
-$295K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$141K |